Obesity Therapy
Imagenetix commences China sales of new patented weight loss product
Published in Obesity and Diabetes Week, May 15th, 2006
The initial order, of 5000 units, will reach market shortly, said Imagenetix. Beijing Yinsheng Pharmaceutics (BYP), a major distributor of health-related goods in China, will distribute the product.
Pending approval from the Ministry of Health, which is expected imminently, Lepitrim will commence general sale throughout China.
Lepitrim is a natural polysaccharide compound that has been found in studies to safely reduce stored fat by lowering the body's levels of leptin, a circulating hormone that regulates fat...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Genetics & Genomics
Agpat6 deficiency causes subdermal lipodystrophy and resistance to obesity - Obesity & Cardiology
High leptin levels in obese may be beneficial to coronary endothelium - Obesity & Cardiology
PPAR-agonist improves left ventricular function in obese dyslipidemic mice - Obesity & Metabolic Syndrome
Obesity and leukocyte count link was dependent on the presence of metabolic syndrome - Obesity Pathogenesis
ENPP1, an insulin receptor inhibitor, is a genetic link between obesity and diabetes - Angiology
Endothelial cell progenitors display differential healing activities - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
